Mount Sinai licenses antibodies to Sorrento for SARS-CoV-2 treatments
March 09 2021 - 01:28PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Sorrento Therapeutics (NASDAQ:SRNE)
Historical Stock Chart
From Feb 2024 to Mar 2024
Sorrento Therapeutics (NASDAQ:SRNE)
Historical Stock Chart
From Mar 2023 to Mar 2024